These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 19401573

  • 21. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
    Kimura K, Tanigawa N, Matsuki M, Nohara T, Iwamoto M, Sumiyoshi K, Tanaka S, Takahashi Y, Narumi Y.
    Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
    [Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness of MR lymphography for the detection of lymph node metastases in patients with prostate cancer.
    Hövels AM, Heesakkers RA, Adang EM, Barentsz JO, Jager GJ, Severens JL.
    Radiology; 2009 Sep; 252(3):729-36. PubMed ID: 19717752
    [Abstract] [Full Text] [Related]

  • 23. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients.
    Barentsz JO, Fütterer JJ, Takahashi S.
    Eur J Radiol; 2007 Sep; 63(3):369-72. PubMed ID: 17689215
    [Abstract] [Full Text] [Related]

  • 24. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience.
    Bellin MF, Roy C, Kinkel K, Thoumas D, Zaim S, Vanel D, Tuchmann C, Richard F, Jacqmin D, Delcourt A, Challier E, Lebret T, Cluzel P.
    Radiology; 1998 Jun; 207(3):799-808. PubMed ID: 9609907
    [Abstract] [Full Text] [Related]

  • 25. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement.
    Michel SC, Keller TM, Fröhlich JM, Fink D, Caduff R, Seifert B, Marincek B, Kubik-Huch RA.
    Radiology; 2002 Nov; 225(2):527-36. PubMed ID: 12409591
    [Abstract] [Full Text] [Related]

  • 26. Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer.
    Triantafyllou M, Studer UE, Birkhäuser FD, Fleischmann A, Bains LJ, Petralia G, Christe A, Froehlich JM, Thoeny HC.
    Eur J Cancer; 2013 Feb; 49(3):616-24. PubMed ID: 23084842
    [Abstract] [Full Text] [Related]

  • 27. High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy.
    Meijer HJ, van Lin EN, Debats OA, Witjes JA, Span PN, Kaanders JH, Barentsz JO.
    Int J Radiat Oncol Biol Phys; 2012 Mar 15; 82(4):1405-10. PubMed ID: 21640507
    [Abstract] [Full Text] [Related]

  • 28. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
    Tabatabaei S, Harisinghani M, McDougal WS.
    J Urol; 2005 Sep 15; 174(3):923-7; discussion 927. PubMed ID: 16093989
    [Abstract] [Full Text] [Related]

  • 29. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
    Taupitz M, Wagner S, Hamm B, Binder A, Pfefferer D.
    AJR Am J Roentgenol; 1993 Jul 15; 161(1):193-200. PubMed ID: 8517301
    [Abstract] [Full Text] [Related]

  • 30. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes.
    Mack MG, Balzer JO, Straub R, Eichler K, Vogl TJ.
    Radiology; 2002 Jan 15; 222(1):239-44. PubMed ID: 11756732
    [Abstract] [Full Text] [Related]

  • 31. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
    Heck MM, Retz M, Bandur M, Souchay M, Vitzthum E, Weirich G, Mollenhauer M, Schuster T, Autenrieth M, Kübler H, Maurer T, Thalgott M, Herkommer K, Gschwend JE, Nawroth R.
    Eur Urol; 2014 Aug 15; 66(2):222-9. PubMed ID: 23465520
    [Abstract] [Full Text] [Related]

  • 32. Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging.
    Warncke SH, Mattei A, Fuechsel FG, Z'Brun S, Krause T, Studer UE.
    Eur Urol; 2007 Jul 15; 52(1):126-32. PubMed ID: 17258385
    [Abstract] [Full Text] [Related]

  • 33. Algorithm for selecting men for pelvic lymph node dissection (PLND) during radical prostatectomy based on clinical risk factors in an Australian population.
    Sengupta S, Weerakoon M, Sethi K, Ischia J, Webb DR.
    BJU Int; 2012 Apr 15; 109 Suppl 3():48-51. PubMed ID: 22458494
    [Abstract] [Full Text] [Related]

  • 34. Cost-analysis of staging methods for lymph nodes in patients with prostate cancer: MRI with a lymph node-specific contrast agent compared to pelvic lymph node dissection or CT.
    Hövels AM, Heesakkers RA, Adang EM, Jager GJ, Barentsz JO.
    Eur Radiol; 2004 Sep 15; 14(9):1707-12. PubMed ID: 15249979
    [Abstract] [Full Text] [Related]

  • 35. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.
    Birkhäuser FD, Studer UE, Froehlich JM, Triantafyllou M, Bains LJ, Petralia G, Vermathen P, Fleischmann A, Thoeny HC.
    Eur Urol; 2013 Dec 15; 64(6):953-60. PubMed ID: 23916692
    [Abstract] [Full Text] [Related]

  • 36. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes.
    Vassallo P, Matei C, Heston WD, McLachlan SJ, Koutcher JA, Castellino RA.
    Radiology; 1994 Nov 15; 193(2):501-6. PubMed ID: 7972768
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography.
    Bellin MF, Lebleu L, Meric JB.
    Abdom Imaging; 2003 Nov 15; 28(2):155-63. PubMed ID: 12592461
    [Abstract] [Full Text] [Related]

  • 38. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10.
    Harisinghani MG, Dixon WT, Saksena MA, Brachtel E, Blezek DJ, Dhawale PJ, Torabi M, Hahn PF.
    Radiographics; 2004 Nov 15; 24(3):867-78. PubMed ID: 15143236
    [Abstract] [Full Text] [Related]

  • 39. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent.
    Pannu HK, Wang KP, Borman TL, Bluemke DA.
    J Magn Reson Imaging; 2000 Dec 15; 12(6):899-904. PubMed ID: 11105028
    [Abstract] [Full Text] [Related]

  • 40. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
    Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C, Wood BJ, Mueller PR.
    AJR Am J Roentgenol; 1999 May 15; 172(5):1347-51. PubMed ID: 10227514
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.